AZE.BR Azelis Group NV EURONEXT slips -8.15% after hours 18 Feb 2026: earnings preview may shift guidance
AZE.BR stock fell -8.15% in after-hours trade to €8.57 on EURONEXT. Volume accelerated to 1355930.00 shares versus an average of 517588.00. The move came ahead of an earnings release scheduled for 19 Feb 2026. Azelis reports specialty chemicals distribution results that can sway guidance. Key ratios today show EPS €0.69 and PE 13.59. Market cap stands at 2282421741.00 EUR. Traders should watch guidance and cash flow metrics tomorrow.
AZE.BR stock: after-hours move and immediate reaction
After the close Azelis traded down to €8.57. The one-day change printed -8.15%. Intraday range was €8.48 to €9.09. The decline suggests investors priced near-term earnings risk into the stock.
Earnings preview and what to watch in the AZE.BR report
Azelis will release results on 19 Feb 2026. Investors will focus on revenue growth and free cash flow. Watch operating cash flow per share of 0.79 and free cash flow per share of 0.71. Management commentary on working capital and net debt is critical given netDebt/EBITDA of 4.37.
Meyka AI stock grade and valuation snapshot
Meyka AI rates AZE.BR with a score out of 100: 72.01, Grade B+, Suggestion BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Valuation shows price-to-sales 0.72 and price-to-book 0.87. Note interest coverage is tight at 1.94, which raises leverage risk.
Technical setup, liquidity and trading signals
Technicals show a neutral to mildly bullish setup. RSI is 56.35 and MACD histogram is 0.10. The 50-day average sits at 9.00, and the 200-day average is 11.57. On-chain volume spike to 1355930.00 suggests higher short-term participation.
Sector context, peers and catalyst calendar
Azelis sits in Basic Materials and Specialty Chemicals. Sector momentum has been mixed with a three-month performance near 0.64%. Comparable distributors face pricing and inventory cycles. Upcoming catalysts include the 19 Feb 2026 earnings and any updated guidance on margin recovery.
Price outlook and analyst context for AZE.BR
Consensus price targets are sparse. Recent third-party ratings show a neutral bias with mixed metric scores. Investors should weigh the year high €20.96 and year low €7.89. Short-term traders may watch the Bollinger Bands at 7.59 and 10.10 for mean reversion.
Final Thoughts
Key takeaways for AZE.BR stock are clear. The share price moved down to €8.57 after hours on 18 Feb 2026. Earnings tomorrow on 19 Feb 2026 are the immediate driver. Liquidity rose to 1355930.00 shares, indicating heavier trading interest. Valuation metrics show a modest price-to-sales ratio of 0.72 and a price-to-book of 0.87. Meyka AI’s forecast model projects a 12-month price of €3.03, implying a theoretical downside of -64.70% versus the current price €8.57. Forecasts are model-based projections and not guarantees. Use the earnings release as a signal. For a quick company snapshot visit Azelis on Meyka: Azelis on Meyka. For market context see competitor comparisons and Belgian market coverage from Investing.com source and a Belgium market roundup source.
FAQs
When does Azelis report earnings and why does it matter?
Azelis reports on 19 Feb 2026. The release matters because guidance on margins and net debt can move AZE.BR stock sharply. Expect commentary on working capital and cash conversion.
What are the main valuation and liquidity metrics for Azelis?
Azelis shows PE 13.59, price-to-sales 0.72, and price-to-book 0.87. Shares outstanding are 243458319.00 and daily volume rose to 1355930.00 in after-hours trading.
How does Meyka AI view AZE.BR stock?
Meyka AI rates AZE.BR 72.01 out of 100, Grade B+, with a BUY suggestion. This grade factors in benchmark and sector comparisons, growth, metrics, and analyst signals.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)